Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2017
Pharma News, 2017
Radical ketamine therapy could treat alcohol addiction
A one-off dose of the drug could help alcohol addicts reduce their intake by ‘erasing’ drink-related memories, say psychologists testing treatment.
Big pharma establishes new industry standards group
Six of the top 25 largest global pharmaceutical companies today announced the formation of Align Biopharma, a new group dedicated to setting technology standards that will make it faster and easier fo...
Does this explain why schizophrenics often smoke? Nicotine helps to reduce the effects of the mental illness, groundbreaking research shows
Smoking helps to reduce the effects of schizophrenia, groundbreaking new research suggests.
India court orders daily TB treatment for millions
Millions of tuberculosis patients in India will receive daily treatment after the Supreme Court Monday ordered the government to change the current dosing practice amid activist claims it was endanger...
WTO IP rules amended to ease poor countries’ access to affordable medicines
An amendment to the agreement on intellectual property entered into force today (23 January) securing for developing countries a legal pathway to access affordable medicines under WTO rules.
Merck to pony up $625M plus Keytruda royalties to settle BMS, Ono patent fight
Merck & Co.
Fosun Pharma and Kite unveil plans for JV
Shanghai Fosun Pharmaceutical (HK.
Statement from FDA Commissioner Robert Califf, M.D. announcing FDA Oncology Center of Excellence launch
Today the U.
FDA approves Aurobindo’s Micardis HCT generic
SILVER SPRING, Md.
Allergan Announces FDA Approval Of RHOFADE™ (Oxymetazoline Hydrochloride) Cream, 1% For The Topical Treatment Of Persistent Facial Erythema Associated With Rosacea In Adults
DUBLIN, Jan.
Teva Receives FDA Approval for VANTRELATM ER (Hydrocodone Bitartrate) Extended-Release Tablets [CII] Formulated with Proprietary Abuse Deterrence Technology
JERUSALEM--(BUSINESS WIRE)--Jan.
FDA approves Trulance from Synergy Pharmaceuticals
The Food and Drug Administration has approved Synergy Pharmaceuticals’s Trulance (plecanatide), the company and agency announced Thursday.
64
65
66
67
68
69
70
71
